Data-driven subtypes of mixed semantic-logopenic primary progressive aphasia: Linguistic features, biomarker profiles and brain metabolic patterns

J Neurol Sci. 2024 May 15:460:122998. doi: 10.1016/j.jns.2024.122998. Epub 2024 Apr 6.

Abstract

Mixed primary progressive aphasia (mPPA) accounts for a substantial proportion of primary progressive aphasia (PPA) cases. However, the lack of a standardised definition of this condition has resulted in misclassification of PPA cases. In this study, we enrolled 55 patients diagnosed with PPA, comprising 12 semantic variant (svPPA), 23 logopenic variant (lvPPA), and 20 mPPA cases with linguistic characteristics consistent with both svPPA and lvPPA (s/lvPPA). All patients underwent language assessments, evaluation of Alzheimer's disease biomarkers (via cerebrospinal fluid analysis or Amyloid-PET), and 18F-FDG-PET brain scans. An agglomerative hierarchical clustering (AHC) analysis based on linguistic characteristics revealed two distinct clusters within the s/lvPPA group: cluster k1 (n = 10) displayed an AD-like biomarker profile, with lower levels of Aβ42 and Aβ42/Aβ40 ratio, along with higher levels of t-tau and p-tau compared to cluster k2 (n = 10). Interestingly, k1 exhibited linguistic features that were similar to those of svPPA. Both clusters exhibited extensive temporoparietal hypometabolism. These findings support the hypothesis that a subgroup of s/lvPPA may represent a clinical manifestation of AD-related PPA.

Keywords: Alzheimer's disease; Biomarkers; Cluster analysis; Frontotemporal dementia; Primary progressive aphasia; Semantic dementia.

Publication types

  • Research Support, Non-U.S. Gov't
  • Research Support, N.I.H., Extramural

MeSH terms

  • Aged
  • Amyloid beta-Peptides / cerebrospinal fluid
  • Amyloid beta-Peptides / metabolism
  • Aphasia, Primary Progressive* / cerebrospinal fluid
  • Aphasia, Primary Progressive* / diagnostic imaging
  • Aphasia, Primary Progressive* / metabolism
  • Biomarkers* / cerebrospinal fluid
  • Brain* / diagnostic imaging
  • Brain* / metabolism
  • Female
  • Fluorodeoxyglucose F18
  • Humans
  • Male
  • Middle Aged
  • Positron-Emission Tomography*
  • Semantics
  • tau Proteins* / cerebrospinal fluid
  • tau Proteins* / metabolism

Substances

  • Biomarkers
  • tau Proteins
  • Amyloid beta-Peptides
  • Fluorodeoxyglucose F18